Screen2Prevent (S2P)
Recruiting
N/A
Interventional Study
HIV Infections
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 14 – 24
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 84,000 (estimated)
- Sponsor
- Westat · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Screen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) by leveraging digital health to identify and link adolescents seeking care in the ED to HIV Pre-Exposure Prophylaxis (PrE…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 14-24 years, inclusive
* Present to the participating ED, regardless of chief complaint during the study period
Exclusion Criteria:
* None
Contacts